You are here

  • Home
  • Archive
  • Volume 10, Issue 4
  • Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center

 

Online download statistics by month:

Online download statistics by month: April 2022 to July 2025

AbstractFullPdf
Apr 2022825857318
May 202226126698
Jun 202216617152
Jul 202214414834
Aug 202214915270
Sep 202217918043
Oct 202215817055
Nov 202210010033
Dec 202211811849
Jan 2023919229
Feb 2023999947
Mar 2023777852
Apr 2023535527
May 2023595930
Jun 2023434334
Jul 2023474725
Aug 2023434415
Sep 2023434319
Oct 2023555728
Nov 2023777712
Dec 2023666628
Jan 2024454726
Feb 2024535426
Mar 2024333470
Apr 2024474837
May 2024535421
Jun 2024737424
Jul 2024697036
Aug 2024686924
Sep 2024474726
Oct 2024595941
Nov 2024596225
Dec 2024717230
Jan 2025626232
Feb 2025494937
Mar 2025545432
Apr 2025676739
May 2025414231
Jun 2025505039
Jul 2025110
Total385439371694